Open-angle glaucoma up 22 percent in last 10 years

Open-angle glaucoma up 22 percent in last 10 years
The prevalence of open-angle glaucoma has increased more than 20 percent in the last 10 years and currently affects more than 2.7 million Americans age 40 years and older, according to a report from Prevent Blindness America and the National Eye Institute.

(HealthDay)—The prevalence of open-angle glaucoma has increased more than 20 percent in the last 10 years and currently affects more than 2.7 million Americans age 40 years and older, according to a report from Prevent Blindness America and the National Eye Institute.

Researchers from Prevent Blindness America, and other leading vision and groups have declared January National Glaucoma Awareness Month in an effort to educate the public on glaucoma. Noting that symptoms develop very gradually, glaucoma can damage if left untreated over time.

According to the report, more than 2.7 million Americans age 40 and older have open-angle glaucoma, an increase of more than 22 percent from 10 years ago. Risk factors for glaucoma include age, family history, nearsightedness, eye injury and surgery, use of steroids, and race. Compared with whites, blacks are five times more likely to have glaucoma and four times more likely to go blind from it. Compared with other groups, Hispanics are more likely to develop glaucoma after age 60. Statins may be effective in the early stages of disease or for prevention, with the risk of glaucoma reduced by 8 percent for hyperlipidemia patients who took statins continuously for two years.

"As we begin 2013, we hope that everyone's New Year's resolution will be to make their eye health a priority and schedule an ," Hugh R. Parry, president and of Prevent Blindness America, said in a statement. "Through early detection and treatment, we can help lessen the effects of glaucoma and other eye diseases on vision."

More information: More Information

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

New technologies for retinal therapies

3 hours ago

The future of the investigation and treatment of retinal disorders is already here at the MedUni Vienna: in the new Christian Doppler "OPTIMA" (Ophthalmic Image Analysis) laboratory headed by Ursula Schmidt-Erfurth, ...

New drug could help AMD sufferers

22 hours ago

There is no cure for age-related macular degeneration, an eye disease that is the leading cause of vision loss and blindness in older Americans. Last year, the National Institutes of Health reported that ...

Researchers find diminished balance in those with poor vision

Jun 06, 2013

UC Davis Health System Eye Center research has found that visually impaired individuals and those with uncorrected refractive error—those who could benefit from glasses to achieve normal vision but don't wear glasses—have ...

User comments

More news stories

Validating maps of the brain's resting state

Kick back and shut your eyes. Now stop thinking. You have just put your brain into what neuroscientists call its resting state. What the brain is doing when an individual is not focused on the outside world ...

No danger of cancer through gene therapy virus

In fall 2012, the European Medicines Agency (EMA) approved the modified adeno-associated virus AAV-LPL S447X as the first ever gene therapy for clinical use in the Western world. uniQure, a Dutch biotech company, had developed ...

Antioxidant shows promise in Parkinson's disease

Diapocynin, a synthetic molecule derived from a naturally occurring compound (apocynin), has been found to protect neurobehavioral function in mice with Parkinson's Disease symptoms by preventing deficits in motor coordination.